COLLA, Simona
 Distribuzione geografica
Continente #
NA - Nord America 322
EU - Europa 261
AS - Asia 126
AF - Africa 2
OC - Oceania 1
Totale 712
Nazione #
US - Stati Uniti d'America 321
CN - Cina 102
IE - Irlanda 92
IT - Italia 56
SE - Svezia 50
DE - Germania 23
SG - Singapore 16
FI - Finlandia 15
CZ - Repubblica Ceca 6
UA - Ucraina 6
IL - Israele 4
TR - Turchia 4
AT - Austria 3
BE - Belgio 2
CI - Costa d'Avorio 2
PT - Portogallo 2
AU - Australia 1
BG - Bulgaria 1
CA - Canada 1
FR - Francia 1
LU - Lussemburgo 1
NL - Olanda 1
RO - Romania 1
RU - Federazione Russa 1
Totale 712
Città #
Chandler 112
Dublin 89
Shanghai 35
Ashburn 31
Parma 26
Beijing 18
Princeton 13
Boardman 12
Singapore 10
Bremen 9
Wilmington 9
Dearborn 8
Milan 8
Nanjing 7
Bologna 5
Brno 5
Jacksonville 5
Kunming 5
San Mateo 5
Hefei 4
Houston 4
Izmir 4
New York 4
Shenyang 4
Changsha 3
Des Moines 3
Hebei 3
Helsinki 3
Jiaxing 3
Lviv 3
Nanchang 3
Rho 3
Vienna 3
Woodbridge 3
Abidjan 2
Ann Arbor 2
Brussels 2
Hangzhou 2
Pescara 2
San Giuliano Milanese 2
Sassuolo 2
Tel Aviv 2
Tianjin 2
Washington 2
West Jordan 2
Zhengzhou 2
Casoria 1
Chengdu 1
Chicago 1
Dallas 1
Düsseldorf 1
Eboli 1
Fairfield 1
Forest City 1
Frankfurt am Main 1
Geislingen an der Steige 1
Huizen 1
Los Angeles 1
Luxembourg 1
Male Hostice 1
Manassas 1
Marseille 1
Munich 1
Palermo 1
Perth 1
Redmond 1
Rockville 1
Santa Clara 1
Seattle 1
Sofia 1
Taizhou 1
Toronto 1
Turin 1
Viterbo 1
Waterford 1
Totale 515
Nome #
ILF2-YB1 Protein Interaction Modulates RNA Splicing to Induce Resistance to Chemotherapy in High Risk Multiple Myeloma 68
A Mouse Model of Telomere Dysfunction Recapitulates Hallmark Features of Human Myelodysplastic Syndrome 66
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 64
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma 63
Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic Syndrome 62
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy 58
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma 50
ILF2-YB1 INTERACTION MODULATES RNA SPLICING TO INDUCE RESISTANCE TO DNA-DAMAGING AGENTS IN 1Q21-AMPLIFIED MULTIPLE MYELOMA 48
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 47
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function 43
PAF promotes stemness and radioresistance of glioma stem cells 41
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer 36
RNA processing: A new player of genomic instability in multiple myeloma 35
Down-regulation of EZH2 expression in myelodysplastic syndromes 28
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy (Nature Medicine, (2022), 28, 3, (557-567), 10.1038/s41591-022-01696-4) 20
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma 7
Totale 736
Categoria #
all - tutte 3.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.168


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202052 0 15 1 1 2 4 7 4 2 8 7 1
2020/202116 0 1 0 10 1 0 1 0 1 1 1 0
2021/202264 7 0 0 0 2 0 1 5 11 6 1 31
2022/2023341 23 40 14 39 28 39 16 19 107 2 12 2
2023/2024174 9 8 3 4 12 20 39 6 10 15 13 35
2024/20258 7 1 0 0 0 0 0 0 0 0 0 0
Totale 736